Cannabis Law Report

JULY 8, 2021

The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. This safety data will support the ensuing preclinical trials in humans to explore the efficacy of the cannabinoids. produced, THC-free 1 CBD products. About cbdMD, Inc. cbdMD, Inc.

Research and Development 111

Research and Development Pets Cannabinoids eCommerce 111

Veriheal

MAY 3, 2022

The study was conducted by more than 10 researchers, with leads Dr. Jodi Gilman and Dr. Kevin Potter taking responsibility for the integrity and accuracy of the data. The outcomes and measures used throughout the trial included changes in CUD symptoms; anxiety and depressive symptoms; pain severity; and insomnia symptoms.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

The Joint Blog

JANUARY 23, 2020

.” For this study, “The first clinically-focused systematic review on the emerging medical application of cannabis across all major psychiatric disorders was conducted.” Preliminary research findings indicate no benefit for depression from high delta-9 tetrahydrocannabinol (THC) therapeutics, or for CBD in mania.

Clinical Trials 52

Clinical Trials Sleep Marijuana Cannabinoids 52

Healer

MARCH 26, 2021

Since 2015, the National Institutes of Health’s National Institute on Drug Abuse has funded research surrounding the therapeutic benefits of tetrahydrocannabinol (THC) and cannabidiol (CBD) for the treatment of pain as an alternative to opioids, addiction and other disorders. So can cannabis help in the fight against opioid addiction?

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

The Joint Blog

MARCH 18, 2021

The study is published in the Journal of Basic and Clinical Physiology and Pharmacology and was epublished by the National Institute of Health. For the study researchers examined data published within the past ten years assessing the use of cannabinoids in patients with PTS. Summary and outlook: .

Cannabinoids 26

Cannabinoids Patients Clinical Trials Research and Development 26

Project CBD

FEBRUARY 27, 2023

Researchers have been investigating the use of cannabis to treat fibromyalgia’s constellation of symptoms for decades, with early clinical trials in the 2000s 1-4 suggesting a possible benefit of both pure THC and flower in managing the disease. It’s not a new idea. © Copyright, Project CBD.

THC 144

THC CBD Sleep Clinical Trials 144

The Cannigma

JUNE 15, 2021

THC is by far the most abundant and popular molecule in marijuana. The two most well known and common cannabinoids are THC and CBD, and while they won’t alter the aroma and colors of cannabis, they do interact with numerous receptor systems in the human body and have a range of effects. CBD vs THC. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease. 14,548. .

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

Greencamp

AUGUST 16, 2018

The ECS plays an important role in managing numerous processes, ranging from sleep, mood, immune functions, metabolism, movement and pain. This is how the psychoactive intoxication with THC affects our brain, and this same pathway is activated for the many other medical benefits cannabis has to offer.

Strains 94

Strains Cannabinoids Research and Development Indica 94

The Joint Blog

JANUARY 12, 2020

As noted by the AP, CBD has garnered a devoted following among people who swear by it for everything from stress reduction to better sleep. Stephanie McGrath, a Colorado State University researcher, is now doing a larger clinical trial funded by the American Kennel Club’s Canine Health Foundation.”

Pets 36

Pets CBD Clinical Trials Research and Development 36

Veriheal

JANUARY 5, 2023

A randomized, double-blind, cross-over trial of cannabis recently published by Research Gate explored whether or not cannabidiol (CBD) — the primary non-intoxicating constituent of cannabis and hemp — improves or reduces the cannabis safety. . Serial plasma concentrations of THC and CBD were also measured. 10 milligrams (1:1).

Clinical Trials 96

Clinical Trials Safety Consumption CBD 96

Project CBD

MAY 3, 2023

Dr. Goldstein: It appears that CBG does a lot of things that THC does and a lot of things that CBD does — but maybe even a little bit better. It’s kind of a bridge between THC and CBD. CannMed: It’s interesting that you say CBG is a bridge between THC and CBD. CBG is not intoxicating or impairing.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. THC is the primary psychoactive compound in cannabis.) Epilepsy Behav.

CBD 144

CBD Seed-To-Sale Food Access 144

The Cannigma

JANUARY 13, 2023

Based on the limited existing evidence, the best cannabis strain for migraines may be a Type II that includes both THC and CBD, and a terpene profile that includes beta-caryophyllene, myrcene, linalool, limonene, bisabolol, humulene or pinene. 5 THC and migraines THC is well-known for its anti-nausea and pain-relieving effects.

Terpenes 132

Terpenes Strains THC Treatment 132

Green Relief

MAY 13, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. CBD produces no intoxicating effects, no THC -like high, and its use does not lead to tolerance. Highlights: According to a U.S.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

JANUARY 9, 2019

Phoenix, headquartered in Denver, distributes medicinal cannabis products around the globe to treat seven major categories of medical conditions including pain, cancer, autoimmune, metabolic, neurological, psychological and sleep disorders. Tindall also hope to commence the clinical trials with Vanuatu for diabetes treatment.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

The Joint Blog

FEBRUARY 18, 2020

” Clinical trial data published in 2017 in in the journal European Neuropsychopharmacology previously reported that the administration of whole-plant cannabis extracts is associated with improvements in cognition and behavior in subjects with ADHD. 9-tetrahydrocannabinol (THC).

Clinical Trials 45

Clinical Trials Terpenes Data Cannabinoids 45

SMPL

MAY 26, 2020

Mr. Laughter and Lawrence Ringo, an old-school hippie grower, were some of the first Americans to intentionally cultivate plants higher in CBD than in THC — the compound that does get you high. At the time of Samantha Miller’s summit in 2011, THC was the sole chemical “face” of the plant. Kerr told me, talking about the night at Ms.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Green Relief

MAY 12, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. CBD produces no intoxicating effects, no THC -like high, and its use does not lead to tolerance. Highlights: According to a U.S.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

The Cannigma

DECEMBER 22, 2021

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. For example, when they open up the CBD-only market, products that will not contain THC, then they will probably find a solution there.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. The recreational use of cannabis is well known and attributed to its power as a psychotropic plant, specifically due to the cannabinoid tetrahydrocannabinol (THC). Data collection. 2016 ; Sznitman et al. years (Atakan 2012 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. A THC version is expected to follow, and potentially one with psychedelic mushrooms. Rick Doblin, Ph.D, in/rickdoblin/ [link].

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51